Group 3 is a category used by IARC to denote agents for which there is inadequate evidence of carcinogenicity in humans and inadequate or limited evidence in experimental animals. This classification does not imply that the substance is non-carcinogenic; rather, it indicates that the available research is insufficient or inconclusive to determine a definitive link to cancer.
